User profiles for Marc Carrier
 | Marc CarrierUniversity of Ottawa, Ottawa Hospital Research Institute Verified email at toh.on.ca Cited by 30802 |
[HTML][HTML] Apixaban to prevent venous thromboembolism in patients with cancer
M Carrier, K Abou-Nassar, R Mallick… - … England Journal of …, 2019 - Mass Medical Soc
Background Patients with active cancer have an increased risk of venous thromboembolism,
which results in substantial morbidity, mortality, and health care expenditures. The Khorana …
which results in substantial morbidity, mortality, and health care expenditures. The Khorana …
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
…, I Weinberg, S Schulman, M Carrier… - Journal of the American …, 2020 - jacc.org
Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the severe acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic …
respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients to thrombotic …
Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism
Background: Case-fatality rates are important for assessing the risks and benefits of
anticoagulation in patients with venous thromboembolism (VTE). Purpose: To summarize case-…
anticoagulation in patients with venous thromboembolism (VTE). Purpose: To summarize case-…
Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report
Background Emerging evidence shows that severe coronavirus disease 2019 (COVID-19)
can be complicated by a significant coagulopathy, that likely manifests in the form of both …
can be complicated by a significant coagulopathy, that likely manifests in the form of both …
[PDF][PDF] Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike
…, G Gendron-Lepage, N Gauthier, M Carrier… - Cell Reports …, 2020 - cell.com
SARS-CoV-2 is responsible for the coronavirus disease 2019 (COVID-19) pandemic, infecting
millions of people and causing hundreds of thousands of deaths. The Spike glycoproteins …
millions of people and causing hundreds of thousands of deaths. The Spike glycoproteins …
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
[HTML][HTML] Screening for occult cancer in unprovoked venous thromboembolism
M Carrier, A Lazo-Langner, S Shivakumar… - … England Journal of …, 2015 - Mass Medical Soc
Background Venous thromboembolism may be the earliest sign of cancer. Currently, there
is a great diversity in practices regarding screening for occult cancer in a person who has an …
is a great diversity in practices regarding screening for occult cancer in a person who has an …
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
…, RD McBane, TJ Zemla, M Carrier… - Blood, The Journal …, 2020 - ashpublications.org
Direct oral anticoagulants (DOACs) are an emerging treatment option for patients with cancer
and acute venous thromboembolism (VTE), but studies have reported inconsistent results. …
and acute venous thromboembolism (VTE), but studies have reported inconsistent results. …
[HTML][HTML] Edoxaban for the treatment of cancer-associated venous thromboembolism
Background Low-molecular-weight heparin is the standard treatment for cancer-associated
venous thromboembolism. The role of treatment with direct oral anticoagulant agents is …
venous thromboembolism. The role of treatment with direct oral anticoagulant agents is …
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid …
Objective To evaluate the effects of therapeutic heparin compared with prophylactic heparin
among moderately ill patients with covid-19 admitted to hospital wards. Design Randomised …
among moderately ill patients with covid-19 admitted to hospital wards. Design Randomised …